New Results
Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation
Jacob B. Swadling, Tobias Warnecke, Kyle L. Morris, Alexis R. Barr
doi: https://doi.org/10.1101/2021.02.04.429742
Jacob B. Swadling
†Institute of Clinical Sciences, Imperial College London, UK
‡MRC London Institute of Medical Sciences, UK
Tobias Warnecke
†Institute of Clinical Sciences, Imperial College London, UK
‡MRC London Institute of Medical Sciences, UK
Kyle L. Morris
‡MRC London Institute of Medical Sciences, UK
Alexis R. Barr
†Institute of Clinical Sciences, Imperial College London, UK
‡MRC London Institute of Medical Sciences, UK
Posted February 04, 2021.
Conserved Cdk inhibitors show unique structural responses to tyrosine phosphorylation
Jacob B. Swadling, Tobias Warnecke, Kyle L. Morris, Alexis R. Barr
bioRxiv 2021.02.04.429742; doi: https://doi.org/10.1101/2021.02.04.429742
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8749)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12086)
- Cell Biology (17403)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16795)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11582)
- Neuroscience (60936)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10423)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)